King Digital Entertainment PLC (NYSE:KING), the developer behind the super addictive Candy Crush Saga, has soft-launched a sequel to their popular game on Tuesday. The new game, called Candy Crush Soda Saga, is available on Google Play Store in selected regions including Sweden, the Netherlands, Spain, and Canada. King Digital Entertainment PLC (NYSE:KING) net profit margin is 30.10% and weekly performance is -2.58%. On last trading day company shares ended up $17.35. King Digital Entertainment PLC (NYSE:KING) distance from 50-day simple moving average (SMA50) is 0.38%.
Delta Air Lines Inc. (NYSE:DAL) Chief Executive Richard Anderson has ambitious plans to build up Seattle as the airline’s West Coast international gateway and its eighth domestic hub. Delta Air Lines, Inc. (NYSE:DAL) shares advanced 1.92% in last trading session and ended the day on $39.24. Gross Margin is 34.50% and its return on assets is 21.90%. Delta Air Lines, Inc. (NYSE:DAL) quarterly performance is 15.17%.
Yelp Inc (NYSE:YELP) and GrubHub Inc (NYSE:GRUB) rose on speculations that they are going to be the next targets for a potential takeover after OpenTable Inc (NASDAQ:OPEN)’s $2.6 million acquisition. Yelp Inc (NYSE:YELP) shares moved up 13.79% in last trading session and were closed at $74.92, while trading in range of $71.83 – $75.68. Yelp Inc (NYSE:YELP) year to date (YTD) performance is 8.66%.
Gilead Sciences, Inc. (NASDAQ:GILD) announced topline results from a Phase 3 clinical trial (GS-US-337-0113) in Japan evaluating the investigational once-daily fixed-dose combination of the NS5A inhibitor ledipasvir (LDV) 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir (SOF) 400 mg, with and without ribavirin (RBV), for the treatment of genotype 1 chronic hepatitis C virus (HCV) infection. Among patients receiving 12 weeks of LDV/SOF without RBV, 100 percent (n=83/83) of treatment-naïve and 100 percent (n=88/88) of treatment-experienced patients achieved a sustained virologic response 12 weeks after completing therapy (SVR12). Among patients receiving LDV/SOF plus RBV, 96 percent (n=80/83) of treatment-naïve and 100 percent of treatment-experienced patients (n=87/87) achieved SVR12. Gilead Sciences, Inc. (NASDAQ:GILD) ended the last trading day at $80.72. Company weekly volatility is calculated as 2.31% and price to cash ratio as 19.16. Gilead Sciences, Inc. (NASDAQ:GILD) showed a negative weekly performance of -2.03%.
Medtronic, Inc. (NYSE:MDT) the second-largest maker of medical devices, agreed to buy Covidien Plc (COV) for $42.9 billion in cash and stock as it transforms into a broader-based company bolstered by new tax advantages. Medtronic will pay the equivalent of $93.22 for each share of Dublin-based Covidien, or about 29 percent more than Covidien’s New York closing price of $72.02 on June 13, the companies said yesterday in a statement. Medtronic, Inc. (NYSE:MDT) net profit margin is 18.00% and weekly performance is -2.83%. On last trading day company shares ended up $60.70. Analysts mean target price for the company is $65.63. Medtronic, Inc. (NYSE:MDT) distance from 50-day simple moving average (SMA50) is 0.97%.
Leave a Reply